See the contents of the event. The programm is an exciting mix of keynote presentations, conversations and panel discussions, intertwined with video clips showcasing good examples and more interactive components. 

10:30     Registration & coffee/tea

11:00-13:00   Inauguration and Introductory   high-level session
11:00-11:20
Welcome remarks
Jan Thesleff, Commissioner General for Sweden Expo2020 Dubai
Niclas Jacobson, Deputy Director-General, Head of Division, Division for EU and International Affairs, Ministry of Health and Social Affairs

Official inauguration by HRH Crown Princess Victoria of Sweden (digital participation)
 
11:20-11:40
Introductory Keynotes: Antibiotic resistance - the silent pandemic (digital participation)
H.E. Lena Hallengren, Minister for Health and Social Affairs of Sweden
Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean
Otto Cars, Professor Infectious Diseases Uppsala University, Founding Director of ReAct

11:40-11:50
Infection Prevention and Control in a Global World – an overview from WHO (digital)
Present situation, progress made, future challenges and how to tackle them,
Benedetta Allegranzi, WHO Technical Lead for Infection Prevention and Control

11:50-11:55
Ilze Melngailis, Senior Director, Business Council for the UN and Private Sector Engagement, UN Foundation

11:55-12.05  
Industry initiatives for the development of new antibiotics
Frida Lundmark, Policy Expert, Lif, the research-based pharmaceutical industry Sweden
 
12:05-13:00    Antibiotic resistance and Infection Prevention and Control
Theme I: Antibiotic resistance – the Silent Pandemic
Discussion on the present situation including effect of the COVID-19 pandemic and how to implement a more preventative approach for antibiotic stewardship. What measures need to be taken, Which are the future challenges and how to tackle them?
 
Theme ll: Changing Behaviours for Better Hygiene & Preventing Infections
Discussion between regional and international healthcare professionals and experts on: Prevention instead of cure, how to change behaviours (awareness, gamification), effects of the pandemic on behaviour, can we measure that change, can we maintain the change? HAI, the importance of training; financing solutions
 
Theme lll: Infection Prevention through Medtech Solutions
Discussion between policy makers, healthcare professionals and the industry on: How can medtech solutions contribute to infections prevention and control, cost-savings, efficiency?
 
Panelists
Johan Carlson, Senior Advisor, former Director General, Public Health Agency of Sweden
H.E. Dr. Farida Al Hosani, Executive Director of Infectious Diseases Sector, Abu Dhabi Public Health Center
Björn Zoëga, CEO, Karolinska University Hospital
Gulnaz Tariq, President World Union for Wound Healing Societies/ Sheikh Khalifa Medical City, Abu Dhabi
Emma Wright, Chief Medical Officer, Mölnlycke
Babak Rashnavadi, Director Business Development SW MEA, Getinge
 
Special presentations on the themes
12:15-12:20     Processes to Combat AMR through Infection Prevention and Control
Dr Bishnu Panigrahi, Group Head – Medical Strategy & Operations Group, Fortis Hospitals, India (digital)

12:35-12:40    
An Industry Perspective on Infection Prevention and AMR
Ulrika Kolsrud, President Health and Medical Solutions, Essity (digital)
 
12:40-12:45    
How to Improve Hand Hygiene through Electronic Monitoring in Healthcare
Karin Granqvist, PhD student, Sahlgrenska University Hospital, Gothenburg Sweden (digital)
 
12:45-12:50    
The HAI Proactive project to Detect and Prevent Infections
Pontus Nauclér, Infectious Diseases Consultant, Karolinska University Hospital, and Lecturer, Karolinska Institutet, Stockholm, Sweden (digital)
 
13:00-14:30    VIP Networking Lunch with Conversations
14:10-14:25
Conversation with former director general of Swedish Public Health Agency Johan Carlson on Sweden’s pandemic response strategy

14:30-15:30    Shifting perspectives from treatment to prevention and early detection of chronic disease 
14:30-14:50    
Theme I: Lifestyle and prevention
Chronic diseases are increasing all over the world with disastrous results shown not least in the light of the Covid pandemic. What does it cost NOT to focus on prevention and chronic disease mgt? How can we contribute to a shift from treatment of sick patients to a healthy population?
Abdullah Rasoud Algwizani,CEO, Public Health Authority, Kingdom of Saudi Arabia (digital participation)
Johan Carlson, Senior Advisor, former Director General, Swedish Public Health Agency
Shereena Almazrouei, Director Health Promotion and Public Health Programs Department, Abu Dhabi Public Health Center

14:55-15:15    
Panel discussion: Find it Early, Treat it Early
How to detect chronic diseases earlier, considering the global increase in incidence, and the problem of detection.
Professor Alistair McGuire, Head of Department of Health Policy, Professor of Health Economics the London School of Economics (digital participation)
Pelin Incesu, Area VP Middle East and Africa, AstraZeneca
 
15:15-15:30   
Healthcare 4.0
The expectations of healthcare in the future, how to become the best hospital in the world quality, efficiency, patient focus, especially looking at digitalization, precision medicine and collaboration.
Björn Zoëga, CEO, Karolinska University Hospital

15:30-16:00    Networking Break
 
16:00-18:00    Co-creating health and care 2030 
16:00-16:10    
Keynote: Empathy and Hi-tech
Anders Ekholm, Director of Analytics, the Swedish Health and Social Care Inspectorate (IVO)
 
16:15-17:45    
Panel discussions on the following topics
Health has become Digital – How do we make the most of it?
The COVID-19 pandemic acts as a catalyst for the digitization of healthcare. How do we make the best of it, and can it contribute to improvements in efficiency and quality at the level of system, healthcare provision and patients?
 
Precision Health and Medicine for the Benefit of Patients
What would be possible to do today (that we don’t do), and what is needed for that to happen? How can we make precision medicine available for everyone? Are there possibilities for “leap frogging” in LMICs? How far can precision health and medicine go? How do we evaluate real benefit for patients?
 
Achieving the Transformation – Partnerships and Innovation collaboration
What can collaboration research/academia + industry achieve, “the Swedish way” of collaboration and examples of interesting and innovative ways of working within healthcare
 
Panelists
H.E. Maryam Matar, Founder and Chairperson, UAE Genetic Diseases Association
Jenni Nordborg, PhD, National Coordinator for Life Sciences, Head of the Office for Life Sciences at the Government, Sweden
Dr.Hamed Al Hashemi, Head of Digital Health Unit /Advisor Chairman Office Department of Health
Niclas Forsling, Project Manager VOPD, Centre for Rural Medicine - Region Västerbotten
 
Special presentations on the themes
16:35-16:40
How Innovative Technology Can Enable Precision Medicine
Andrea Ballagi, Vice President Sales and Marketing, Olink Proteomics

17:10-17:15
Applying solution from other sectors to healthcare
Paul Baratta, Segment Development Manager, Healthcare, Axis Communications (digital)
 
17:25-17:30
Power of trusted partnerships for truly amazing outcomes
Sara Thomas, Clinical Director Arjo MOVE Arjo (digital)
 
17:50-18:00     Concluding reflections
What I learnt in studying medicine in Sweden
Fatma al Jassim, Swedish alumni, Consultant Pediatrician and Pediatric Pulmonologist, Dubai Health Authority

Invitation to reception
Anna Riby, Regional Director, Swecare
 
18:00- 20:00    Roof top reception

09:30     Registration & coffee/tea

Introductory Session
10.00-10:05
Welcome to the World Cancer Event by Sweden – opening and introduction
 
10:05-10:25
Setting the Scene – the Global Burden of Cancer
Cancer is a disease that does not discriminate, it affects individuals alike across different geographical, social and financial settings. The growing burden of cancer is a major public health threat which no healthcare system seems sufficiently prepared to tackle alone because of its scale and complexity.
Hans Hägglund, MD, Professor, National Cancer Coordinator at the Swedish Association of Local Authorities and Regions, chair of the Confederation of Regional Cancer Centres, co-founder and chair of Vision Zero Cancer, Sweden
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer, AstraZeneca (digital)

10:25-10:35     
Inspirational keynote: Innovation and leadership in the new normal (digital participaton)
The new normal will require a fundamental change in the way we create innovation and lead our organizations. This is the moment to collectively re-build a new economy and a new world, by fostering a cooperative mindset, by sharing data and learnings.
Roberto Verganti, Professor of Leadership and Innovation, House of Innovation, Stockholm School of Economics
 
Theme I: New Paradigms for Research and Innovation
10:35-10:55     
Keynote: Cancer and the role of research in innovating for change
We are working towards a future where healthcare is more human-centred, with patients involved in research as an option within the care ecosystem. Refocusing clinical research around the patient experience demands a rethink in how we design and deliver clinical trials as well as care.

10:40-10:55   
Keynote: Cancer and the role of Role of Research in Innovating for Change (digital)
Anna Martling, Professor of Surgery at Karolinska Institutet (KI) and Senior Consultant Colorectal Surgeon at Karolinska University Hospital, Stockholm, Campus Dean
 
10:55-11:25    
Panel discussion on Refocusing Clinical Research and Innovation around the Patient Experience
Asma Al Mannaei, Executive Director Research and Innovation Center, Department of Health - Abu Dhabi
Bettina Ryll, MD, PhD, Subject matter expert Personalised Medicine and Patient-centric Innovation at Vision Zero Cancer, Founder Melanoma Patient Network Europe, member of the first EU cancer mission board
Itedale Namro Redwan, PhD, Chief Scientific Officer, Cellink
Vesa Kataja, MD, Professor, Chief Medical Officer, Kaiku Health – a part of Elekta
 
11:30-12:00     Break & Networking
 
Theme II: A New Age for Prediction and Early Detection of Cancer

12:00               
Keynote: Saving Lives Through Sustainable Cancer Prevention and Earlier Detection (digital)
Beatrice Melin, MD, PhD, Professor in Oncology at Umeå University, Director of Research Development and Innovation at Region Västerbotten, Sweden

12:15-12:30    
Examples on Progress in Prediction and Screening Technologies (digital presentations)
Improving the quality of breast cancer screening programmes using 3D mammography and AI
Sophia Zackrisson, MD, Associate Professor, Department of Translational Medicine, Diagnostic Radiology, Lund University, Skåne University Hospital Malmö, Sweden
 
Towards personalised risk-based prostate cancer diagnostic programmes (A better way to diagnose Prostate cancer)
Henrik Grönberg, MD, PhD, Professor in Cancer Epidemiology, Karolinska Institutet, Sweden and Head of Prostate Cancer Center, Capio St Göran Hospital
 
LDCT screening for lung cancer: the next big opportunity in cancer detection
David CL Lam, MD, PhD, Clinical Associate Professor, Department of Medicine, University of Hong Kong

12:30-13:00    
Panel discussion: Optimizing Access to Screening and Novel Approaches for Early Detection
Dr. Hans Hägglund, MD, Professor, National Cancer Coordinator at the Swedish Association of Local Authorities and Regions, chair of the Confederation of Regional Cancer Centres, co-founder and chair of Vision Zero Cancer, Sweden
H.E. Omniyat Al Hajeri, Executive Director of Community Health Sector, Abu Dhabi Public Health Center
Humaid Al Shamsi, MD, Professor, Founder and Director of the Medical Oncology Service at Burjeel Medical City - VPS healthcare
Björn Zoëga, CEO Karolinska University Hospital
Andrea Ballagi, MD, PhD, MBA, Vice president Sales and Marketing, Olink Proteomics

13:00-14:25     VIP Networking Lunch
 
Theme III: Digital Transformation and Personalization of Cancer Care
14:30-14:45    
Keynote: The Road Towards Personalized Cancer Care (digital)
Richard Rosenquist Brandell, MD, PhD, Professor of Clinical Genetics at Karolinska Institutet and Senior Consultant at Karolinska University Hospital, Chair of Genomic Medicine Sweden (GMS), Member of the Nobel Assembly
 
14:45-15:00    
Keynote: AI, Big Data and Equitable Access to Cancer Care: What is the Potential? (digital)
Wilfred Ngwa, Ph.D., M.Sc., Associate Professor (PAR) of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine
 
15:00-15:10  
How innovative radiotherapy has become critical tool for precision multidisciplinary cancer treatment
Bora Tas, PhD Medical Physics, Associate professor, Physicist, Director MR Linac Region Turkey, India, Middle East and Africa at Elekta
 
15:15-15.20
Patient selection test to match therapeutics with patients
Acrivon Therapeutics
 
15:30-16:00    
Panel discussion: Addressing the Challenges to Global Adoption of Precision Health
The role of genomic innovation and personalisation of cancer care in a global context. How do we address the challenges to global adoption? How can the technologies and systems involved contribute to greater sustainability, more effective and resilient health systems and greater access to care and improved outcomes globally? 
 
Humaid Al Shamsi, MD, Professor, Founder and Director of the Medical Oncology Service, Burjeel Medical City, VPS healthcare
Bettina Ryll, MD, PhDSubject matter expert Personalised Medicine and Patient-centric Innovation at Vision Zero Cancer, Founder Melanoma Patient Network Europe, member of the first EU cancer mission board
Frida Lundmark, PhD, Policy Expert, Lif - The research-based pharmaceutical industry Sweden
 
16:00-16:30     Break & Networking
 
Theme IV: Connecting Minds – Creating the Future of Cancer Control
16:30-16:45    
Keynote: Digital Health R&I Holds the Potential to Reimagine Healthcare (digital)
Digital health technologies and AI holds enormous potential to reimagine healthcare, with the scaling of digital patient solutions to improve health outcomes. We can already envisage a future where digital solutions have completely changed how healthcare is delivered, with patients more connected and in charge of their care than ever before. This digital transformation enables the uptake of precision medicine.
Cristina Durán, Chief Digital Health Officer R&D at AstraZeneca

16:45-17:00 
India-Sweden Healthcare Centre of Excellence
Announcement of the Centre of Excellences by the India-Sweden Healthcare Innovation Center at AIIMS Jodhpur, India
 
17:00-17:15   
A rapid poll with selected speakers, panelists and distinguished participants: The Magic of Innovation through Collaboration towards a Vision Zero for Cancer
Highlighting the results from the day and reflections on the way forward to achieve the transformation through Partnerships and Innovation

17:15-17:30    Closing Ceremony
17:15-17:20    
Health system innovation to improve cancer care and address inequity – closing keynote
H.E. Lena Hallengren, Minister for Health and Social Affairs
 
17:20-17:30    
Concluding conversation on the Swedish Life Science Programme
Ebba Hallersjö Hult, Head of Vision Zero Cancer
Anna Riby, Regional Director, Swecare
Jan Thesleff, Commissioner General for Sweden Expo2020 Dubai
Highlighting the results from tobday's co-creation Reflections from the two days in the Swedish pavilion and the way forward to achieve the transformation, through Partnerships and Innovation.

17:30-19:00    Networking Reception